- Home
- APPS vs BME Comparison
APPS vs BME Comparison
Compare APPS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPS
- BME
- Stock Information
- Founded
- APPS N/A
- BME 2005
- Country
- APPS United States
- BME United States
- Employees
- APPS N/A
- BME N/A
- Industry
- APPS Multi-Sector Companies
- BME Trusts Except Educational Religious and Charitable
- Sector
- APPS Miscellaneous
- BME Finance
- Exchange
- APPS Nasdaq
- BME Nasdaq
- Market Cap
- APPS 555.2M
- BME 462.3M
- IPO Year
- APPS N/A
- BME N/A
- Fundamental
- Price
- APPS $5.81
- BME $36.81
- Analyst Decision
- APPS Hold
- BME
- Analyst Count
- APPS 3
- BME 0
- Target Price
- APPS $3.33
- BME N/A
- AVG Volume (30 Days)
- APPS 11.3M
- BME 34.0K
- Earning Date
- APPS 06-16-2025
- BME 01-01-0001
- Dividend Yield
- APPS N/A
- BME 6.26%
- EPS Growth
- APPS N/A
- BME N/A
- EPS
- APPS N/A
- BME 1.44
- Revenue
- APPS $490,506,000.00
- BME N/A
- Revenue This Year
- APPS $9.10
- BME N/A
- Revenue Next Year
- APPS $8.12
- BME N/A
- P/E Ratio
- APPS N/A
- BME $28.37
- Revenue Growth
- APPS N/A
- BME N/A
- 52 Week Low
- APPS $1.18
- BME $35.53
- 52 Week High
- APPS $7.77
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- APPS 55.26
- BME 60.88
- Support Level
- APPS $4.97
- BME $35.30
- Resistance Level
- APPS $6.28
- BME $35.89
- Average True Range (ATR)
- APPS 0.72
- BME 0.42
- MACD
- APPS -0.04
- BME 0.09
- Stochastic Oscillator
- APPS 37.27
- BME 88.53
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.